Search

Your search keyword '"Craine, N."' showing total 87 results

Search Constraints

Start Over You searched for: Author "Craine, N." Remove constraint Author: "Craine, N."
87 results on '"Craine, N."'

Search Results

2. HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

3. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

4. SARS-CoV-2 evolution during treatment of chronic infection

7. Genomic reconstruction of the SARS-CoV-2 epidemic in England

9. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

11. Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?

12. The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual

14. The dynamics of heroin use; implications for intervention

15. Intervention Now To Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT):a systematic review of intervention effectiveness and cost-effectiveness, qualitative and realist synthesis of implementation factors and user engagement

16. HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

18. Intervention Now To Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, qualitative and realist synthesis of implementation factors and user engagement

19. Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales.

20. Hepatitis C testing and injecting risk behaviour: the results of a UK based pilot study.

22. Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling

23. Genomic reconstruction of the SARS-CoV-2 epidemic in England

24. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

25. Recurrent SARS-CoV-2 mutations in immunodeficient patients

26. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

27. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

28. The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis

29. Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer

30. Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021

31. The comparison of the diversity of activated sludge plants

32. SARS-CoV-2 incidence among teaching staff in primary and secondary schools-Wales, 2020-2021.

33. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.

34. If it ain't broke don't fix it: Lack of review of antimicrobials in 'well' patients - time for a CRP change.

35. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing.

36. WGS to determine the extent of Clostridioides difficile transmission in a high incidence setting in North Wales in 2015.

37. Cost-Effectiveness Analysis of the Use of Point-of-Care C-Reactive Protein Testing to Reduce Antibiotic Prescribing in Primary Care.

38. Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?

39. Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trial.

40. Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement.

41. The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual.

42. Outbreak of syphilis in men who have sex with men living in rural North Wales (UK) associated with the use of social media.

43. Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement.

44. Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.

45. A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons.

46. Developing blood borne virus services across prisons in Wales, UK.

47. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

48. Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.

49. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales.

Catalog

Books, media, physical & digital resources